News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-21 9:43:15 am Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript SeekingAlpha
2024-02-21 5:45:2 am Theratechnologies: Fiscal Q4 Earnings Snapshot Associated Press Finance
2024-02-21 4:30:0 am Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance GlobeNewswire
2024-02-20 4:30:0 am Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action GlobeNewswire
2024-02-15 4:30:0 am Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer GlobeNewswire
2024-02-06 4:30:0 am Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update GlobeNewswire
2024-01-31 3:39:54 am Positive Signs As Multiple Insiders Buy Theratechnologies Stock Simply Wall St.
2024-01-24 4:0:0 am Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA GlobeNewswire
2024-01-23 4:30:0 am Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information